• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在胰岛素和肝素存在的情况下,单一及联合抗菌药物在各种腹膜透析液中的稳定性。

Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparin.

作者信息

Sewell D L, Golper T A, Brown S D, Nelson E, Knower M, Kimbrough R C

出版信息

Am J Kidney Dis. 1983 Nov;3(3):209-12. doi: 10.1016/s0272-6386(83)80064-x.

DOI:10.1016/s0272-6386(83)80064-x
PMID:6356893
Abstract

The antimicrobial activity of ampicillin, azlocillin, cefotaxime, cephapirin, clindamycin, mezlocillin, nafcillin, piperacillin, tobramycin, and vancomycin was tested in peritoneal dialysate at room temperature for 24 hours and 48 hours. All of the antimicrobial agents were active at 24 hours. The bioactivity of cefotaxime, nafcillin, and vancomycin declined 15% to 20% after 48 hours (P less than 0.001). The addition of heparin or insulin did not affect the activity of any of the study drugs. The combination of cephapirin and tobramycin remained bioactive for 24 hours at room temperature and 35 degrees C. The preparation of drug-dialysate solution every one to two days is feasible for the treatment of peritonitis in patients on continuous ambulatory or continuous cycled peritoneal dialysis.

摘要

在室温下,对氨苄西林、阿洛西林、头孢噻肟、头孢匹林、克林霉素、美洛西林、萘夫西林、哌拉西林、妥布霉素和万古霉素在腹膜透析液中的抗菌活性进行了24小时和48小时的测试。所有抗菌药物在24小时时均有活性。48小时后,头孢噻肟、萘夫西林和万古霉素的生物活性下降了15%至20%(P小于0.001)。添加肝素或胰岛素不影响任何一种研究药物的活性。头孢匹林和妥布霉素的组合在室温和35摄氏度下24小时内仍保持生物活性。对于持续非卧床腹膜透析或持续循环腹膜透析的患者,每1至2天制备一次药物 - 透析液溶液用于治疗腹膜炎是可行的。

相似文献

1
Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparin.在胰岛素和肝素存在的情况下,单一及联合抗菌药物在各种腹膜透析液中的稳定性。
Am J Kidney Dis. 1983 Nov;3(3):209-12. doi: 10.1016/s0272-6386(83)80064-x.
2
Stability of antimicrobial agents in peritoneal dialysate.抗菌剂在腹膜透析液中的稳定性。
Antimicrob Agents Chemother. 1982 Mar;21(3):528-9. doi: 10.1128/AAC.21.3.528.
3
Antibiotic activity in peritoneal dialysate.腹膜透析液中的抗生素活性。
Am J Kidney Dis. 1983 Nov;3(3):205-8. doi: 10.1016/s0272-6386(83)80063-8.
4
Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.儿童腹膜透析相关性腹膜炎连续与间歇应用万古霉素/替考拉宁及头孢他啶治疗:一项前瞻性随机试验的初步结果。APN儿科肾脏病工作小组成员。
Adv Perit Dial. 1995;11:296-301.
5
Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.在接受持续性非卧床腹膜透析和持续性循环腹膜透析的终末期肾病患者中,使用大剂量腹腔内氨基糖苷类药物治疗腹膜炎。
Adv Perit Dial. 2000;16:280-4.
6
Prolonged stability of antimicrobial activity in peritoneal dialysis solutions.腹膜透析液中抗菌活性的长期稳定性。
Perit Dial Int. 2003 Jan-Feb;23(1):58-62.
7
Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.美罗培南联合妥布霉素继以美罗培南联合万古霉素治疗持续性非卧床腹膜透析患者腹膜炎的疗效及安全性
Adv Perit Dial. 2006;22:65-8.
8
Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.克林霉素磷酸酯腹腔给药后在持续性不卧床腹膜透析患者血浆和透析液中的药代动力学:一项开放标签、前瞻性、单剂量、两机构研究。
Basic Clin Pharmacol Toxicol. 2012 Jun;110(6):504-9. doi: 10.1111/j.1742-7843.2011.00842.x. Epub 2012 Jan 16.
9
Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者腹腔内注射头孢噻肟治疗腹膜炎的药代动力学
Nephron. 1985;40(1):79-82. doi: 10.1159/000183433.
10
Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.头孢噻肟在血液透析和持续性非卧床腹膜透析患者中的药代动力学
J Antimicrob Chemother. 1984 Sep;14 Suppl B:135-42. doi: 10.1093/jac/14.suppl_b.135.

引用本文的文献

1
Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility.以文化为导向的腹膜透析液中的抗生素:一项关注稳定性和相容性的系统评价。
J Nephrol. 2023 Sep;36(7):1841-1859. doi: 10.1007/s40620-023-01716-7. Epub 2023 Aug 7.
2
In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.庆大霉素、头孢唑林和亚胺培南在腹膜透析液中的体外杀菌活性。
Antimicrob Agents Chemother. 1989 Sep;33(9):1553-6. doi: 10.1128/AAC.33.9.1553.